Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06331754
Other study ID # ATMANHEALTH001
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 18, 2024
Est. completion date March 17, 2026

Study information

Verified date March 2024
Source Atman Health, Inc
Contact Rahul C Deo, MD PhD
Phone 339-204-5454
Email rahul@atmanhealth.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objective of this study is to reliably estimate the difference in blood pressure control of a technology-enabled solution for blood pressure (BP) management over usual care. The study will also assess patient and provider satisfaction with the solution. Finally, the investigators will estimate the economic impact of the intervention in terms of resource utilization.


Description:

The study design is a non-blinded pragmatic cluster-randomized controlled trial with a single intervention. Participants with uncontrolled hypertension will be identified from a randomly selected group of primary care clinics. Participants from half of the clinics will be enrolled in the intervention arm while the others will receive usual care. Participants in the intervention arm will undergo a series of software-driven medication initiation and titration steps until they reach a blood pressure target of systolic blood pressure < 130 mmHg and diastolic blood pressure < 80 mmHg. Participants will be subsequently monitored for up to 12 more months.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 1500
Est. completion date March 17, 2026
Est. primary completion date September 17, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - 18 years - 100 years - uncontrolled hypertension: as defined as SBP > 140 or DBP > 90 on 2 successive clinic visits Exclusion Criteria: - hearing impaired - visually impaired - cognitively impaired - hospice care - on hemodialysis at enrollment - New York Heart Association Class IV heart failure

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Technology-enabled blood pressure management
The intervention will consist of a technology-enabled remote hypertension management program.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Atman Health, Inc

Outcome

Type Measure Description Time frame Safety issue
Other Home measured change in SBP and DBP Home measured change in blood pressure in intervention group - more accurately measured: overall and by patient group 6 months
Other Patient satisfaction A patient satisfaction survey with questions similar to the Consumer Assessment of Healthcare Providers and Systems will be used. 6 months
Other Provider satisfaction A survey instrument will be developed and administered to assess provider satisfaction with having a remote team manage their patients. 6 months
Other Mean time required per patient for provider Cumulative time in minutes for all interactions, including documentation. 6 months
Other Mean time required per patient for navigator Cumulative time in minutes for all interactions, including documentation. 6 months
Other Proportion of patients measuring blood pressure at directed frequency Proportion of patients measuring blood pressure at least twice a day during active management period. 6 months
Other Resource utilization Difference in resource utilization between intervention and usual care for different patient groups using claims data. 18 months
Primary Difference in SBP change Difference in mean change in systolic blood pressure (SBP) 6 months after enrollment
Secondary HEDIS proportion Difference in the proportion of patients meeting HEDIS definition of controlled hypertension (SBP < 140 AND DBP < 90) between intervention and usual care: overall and by patient group and by age, race, sex strata 6 months after enrollment
Secondary Difference in DBP change Difference in mean change in diastolic blood pressure (DBP) 6 months after enrollment
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A